Source: Eur Respir J, 50 (4) 1701183; 10.1183/13993003.01183-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Rita Pavasini, Francesco Vieceli dalla Sega, Francesco Gallo, Giulia Passarini, Alberto Papi, Marco Contoli, Gianluca Campo. Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial. Eur Respir J, 50 (4) 1701183; 10.1183/13993003.01183-2017

Member's Comments

No comment yet.

Related content which might interest you: Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Systemic inflammatory profile of patients with acute coronary syndrome and concomitant COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Evaluation of endothelial dysfunction at the patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Endothelial dysfunction as a predictor of hypercoagulable disorders in patients with COPD Source: International Congress 2019 – Clinical problems Year: 2019 Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome Source: ERJ Open Res, 7 (4) 00496-2021; 10.1183/23120541.00496-2021 Year: 2021 Endothelial dysfunction in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Endothelial dysfunction of patients with pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002 Vascular wall remodeling in patients with chronic thromboembolic pulmonary hypertension: a role for C-reactive protein Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Platelet function in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease Year: 2009 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Respiration function by patients with acute coronary syndrome Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Endotelialny dysfunction at patients with COPD and coronary heart disease Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Circulating endothelial cell levels decrease after vasodilator therapy and are a biomarker of clinical worsening in refractory pulmonary hypertension in children Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Microvascular changes in COPD patients with severe pulmonary hypertension Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Platelet activity in patients with COPD and concomitant arterial hypertension Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 The study of the damage degree of myocardial coronary blood flow in patients with chronic obstructive pulmonary disease and severe bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008